Patents by Inventor Rhonda Hansen

Rhonda Hansen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GENE PRODUCTS DIFFERENTIALLY EXPRESSED IN CANCEROUS CELLS
    Publication number: 20120308569
    Abstract: The present invention provides polynucleotides, as well as polypeptides encoded thereby, that are differentially expressed in cancer cells. These polynucleotides are useful in a variety of diagnostic and therapeutic methods. The present invention further provides methods of reducing growth of cancer cells. These methods are useful for treating cancer.
    Type: Application
    Filed: June 7, 2012
    Publication date: December 6, 2012
    Applicant: NOVARTIS VACCINES & DIAGNOSTICS, INC.
    Inventors: Vivien W. CHAN, Jaime Escobedo, Pablo Dominguez Garcia, Rhonda Hansen, Joerg Kaufmann, Giulia C. Kennedy, George Lamson, Edward J. Moler, Filippo Randazzo, Christoph Reinhard, Julie Sudduth-Klinger
  • Gene products differentially expressed in cancerous cells
    Patent number: 8221983
    Abstract: The present invention provides polynucleotides, as well as polypeptides encoded thereby, that are differentially expressed in cancer cells. These polynucleotides are useful in a variety of diagnostic and therapeutic methods. The present invention further provides methods of reducing growth of cancer cells. These methods are useful for treating cancer.
    Type: Grant
    Filed: March 16, 2010
    Date of Patent: July 17, 2012
    Assignee: Novartis Vaccines and Diagnostics, Inc.
    Inventors: Vivien W. Chan, Jaime Escobedo, Pablo Dominguez Garcia, Rhonda Hansen, Joerg Kaufmann, Giulia C. Kennedy, George Lamson, Edward J. Moler, Filippo Randazzo, Christoph Reinhard, Julie Sudduth-Klinger
  • Methods of modulating metastasis and skeletal related events resulting from metastases
    Patent number: 8012681
    Abstract: The invention provides, inter alia, models of bone metastasis, methods for identifying agents that modulate skeletal related events and metastasis, methods for modulating skeletal related events and metastases, and methods for detecting skeletal related events and metastases. The methods and models generally comprise co-culturing cancer cells and host cells and comparing biological markers from such co-cultured cells to control cells.
    Type: Grant
    Filed: May 12, 2004
    Date of Patent: September 6, 2011
    Assignee: Novartis Vaccines and Diagnostics, Inc.
    Inventors: Deborah Lee Zimmerman, Rhonda Hansen, Jill Winter, Christoph Reinhard, Shuling Fang
  • GENE PRODUCTS DIFFERENTIALLY EXPRESSED IN CANCEROUS CELLS
    Publication number: 20100233187
    Abstract: The present invention provides polynucleotides, as well as polypeptides encoded thereby, that are differentially expressed in cancer cells. These polynucleotides are useful in a variety of diagnostic and therapeutic methods. The present invention further provides methods of reducing growth of cancer cells. These methods are useful for treating cancer.
    Type: Application
    Filed: March 16, 2010
    Publication date: September 16, 2010
    Inventors: Vivien W. Chan, Jaime Escobedo, Pablo Dominguez Garcia, Rhonda Hansen, Joerg Kaufmann, Giulia C. Kennedy, George Lamson, Edward J. Moler, Filippo Randazzo, Christoph Reinhard, Julie Sudduth-Klinger
  • Gene products differentially expressed in cancerous cells
    Patent number: 7700359
    Abstract: The present invention provides polynucleotides, as well as polypeptides encoded thereby, that are differentially expressed in cancer cells. These polynucleotides are useful in a variety of diagnostic and therapeutic methods. The present invention further provides methods of reducing growth of cancer cells. These methods are useful for treating cancer.
    Type: Grant
    Filed: September 22, 2004
    Date of Patent: April 20, 2010
    Assignee: Novartis Vaccines and Diagnostics, Inc.
    Inventors: Vivien W. Chan, Jaime Escobedo, Pablo Dominguez Garcia, Rhonda Hansen, Joerg Kaufmann, Giulia C. Kennedy, George Lamson, Edward J. Moler, Filippo Randazzo, Christoph Reinhard, Julie Sudduth-Klinger
  • Methods of Modulating Metastasis and Skeletal Related Events Resulting From Metastases
    Publication number: 20080241067
    Abstract: The invention provides, inter alia, models of bone metastasis, methods for identifying agents that modulate skeletal related events and metastasis, methods for modulating skeletal related events and metastases, and methods for detecting skeletal related events and metastases. The methods and models generally comprise co-culturing cancer cells and host cells and comparing biological markers from such co-cultured cells to control cells.
    Type: Application
    Filed: May 12, 2004
    Publication date: October 2, 2008
    Inventors: Deborah Lee Zimmerman, Rhonda Hansen, Jill Winter, Christoph Reinhard, Shuling Fang
  • Gene products differentially expressed in cancerous cells III
    Publication number: 20070010469
    Abstract: The present invention provides polynucleotides, as well as polypeptides encoded thereby, that are differentially expressed in cancer cells. These polynucleotides are useful in a variety of diagnostic and therapeutic methods. The present invention further provides methods of reducing growth of cancer cells. These methods are useful for treating cancer.
    Type: Application
    Filed: September 22, 2004
    Publication date: January 11, 2007
    Inventors: Vivien Chan, Jaime Escobedo, Pablo Garcia, Rhonda Hansen, Joerg Kaufmann, Giulia Kennedy, George Lamson, Edward Moler, Filippo Randazzo, Christoph Reinhard, Julie Sudduth-Klinger
  • Gene products differentially expressed in cancerous breast cells and their methods of use
    Publication number: 20060141455
    Abstract: The present invention provides polynucleotides, as well as polypeptides encoded thereby, that are differentially expressed in breast cancer cells. These polynucleotides are useful in a variety of diagnostic and therapeutic methods. The present invention further provides methods of reducing growth of breast cancer cells. These methods are useful for treating breast cancer.
    Type: Application
    Filed: January 8, 2003
    Publication date: June 29, 2006
    Inventor: Rhonda Hansen
  • Self-cooling joint connection for abutting segments in a gas turbine engine
    Patent number: 5167485
    Abstract: A joint connection for abutting, circumferentially extending segments in a gas turbine engine, such as turbine nozzle segments, includes a sealing member which is insertable between longitudinally extending slots formed in the abutting side edges of two adjacent segments. The segments are each formed with a number of grooves which are longitudinally spaced along the length of the slots therein, and which extend beneath the sealing member carried within the slots. A cooling air flow path is thus formed extending from one side of the sealing member, into the longitudinal slot of each segment and then through the grooves to the opposite side of the sealing member so that the entire joint connection or seal region between the abutting side edges of the segments is cooled.
    Type: Grant
    Filed: April 6, 1992
    Date of Patent: December 1, 1992
    Assignee: General Electric Company
    Inventor: John H. Starkweather